The goals of the Biostatistics and Bioinformatics Core are to address the study design and analysis needs of the Yale SPORE in Skin Cancer (YSPORE) projects, the Developmental Research Program (DRP), and the Career Development Program (CDP), and to address the analytical and data management needs of the Biospecimen Core. Drs. Krauthammer and Ma will continue to serve as Co-Directors of this Core, and will be assisted by statisticians and bioinformatitions with unique expertise and extensive experience.
The Specific Aims of the Biostatistics and Bioinformatics Core are as follows.
Aim 1 : Provide biostatistical and bioinformatics support to all YSPORE projects and investigators. The Core will provide timely and comprehensive support to address questions arising from the YSPORE projects. Our service will cover the whole spectrum of the studies, including study design, data management and analysis, result interpretation, and preparation of manuscripts, abstracts, posters, and applications. The Core will have regular research meetings with YSPORE investigators and maintain an open door policy for all analytic needs.
Aim 2 : Provide effective data management for YSPORE projects. The Core will offer data management services to all projects and investigators and ensure that all NIH data-sharing regulations are properly followed. This includes deposit of properly curated data to repositories such as GEO, SRA, dbGaP, and others.
Aim 3 : Develop innovative biostatistical and bioinformatic methods tailored to melanoma research. Data with more complex characteristics will be generated by YSPORE, TCGA, and other studies. As an independent intellectual contribution, the Core will develop new analysis methods which will facilitate more effective utilization of data and foster melanoma analytic research.
Aim 4 : Promote program- specific research and training opportunities involving biostatistics and bioinformatics trainees and faculty. The Core will promote opportunities within existing Yale programs and centers, including the Yale Graduate Program for Computational Biology and Bioinformatics (CBB), Yale Center for Medical Informatics (YCMI), Yale Center for Analytic Sciences (YCAS), and others. During the past and current funding period, the Core has made significant contributions to research and training, which is partly reflected in our strong publication record and successes in training postdoc associates and graduate students. We will continue to do so in the proposed funding period. The Core will borrow strength while not overlap with that of other SPORE(s) and Yale Comprehensive Cancer Center (YCC). The Core will also be a key partner in the YSPORE with representation on the Senior Leadership Team and participation in all key meetings.

Public Health Relevance

With a stellar team of bioinformaticians and biostatisticians, the Core will provide the whole spectrum of analytic support to all YSPORE projects and investigators. The Core will ensure that all studies are properly designed and executed and that data are properly managed, analyzed, reported, and published.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
2P50CA121974-11A1
Application #
9567745
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2018-09-01
Budget End
2019-08-31
Support Year
11
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Yale University
Department
Type
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
Ferrucci, Leah M; Cartmel, Brenda; Clare, Rachel A et al. (2018) Cross-sectional assessment of ultraviolet radiation-related behaviors among young people after a diagnosis of melanoma or basal cell carcinoma. J Am Acad Dermatol 79:149-152
Arbesman, Joshua; Ravichandran, Sairekha; Funchain, Pauline et al. (2018) Melanoma cases demonstrate increased carrier frequency of phenylketonuria/hyperphenylalanemia mutations. Pigment Cell Melanoma Res 31:529-533
Perry, Curtis J; Muñoz-Rojas, Andrés R; Meeth, Katrina M et al. (2018) Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity. J Exp Med 215:877-893
Liu, Xiaoni; Zhang, Shang-Min; McGeary, Meaghan K et al. (2018) KDM5B Promotes Drug Resistance by Regulating Melanoma Propagating Cell Subpopulations. Mol Cancer Ther :
Sulkowski, Parker L; Scanlon, Susan E; Oeck, Sebastian et al. (2018) PTEN Regulates Nonhomologous End Joining By Epigenetic Induction of NHEJ1/XLF. Mol Cancer Res 16:1241-1254
Chen, Ling; Azuma, Takeshi; Yu, Weiwei et al. (2018) B7-H1 maintains the polyclonal T cell response by protecting dendritic cells from cytotoxic T lymphocyte destruction. Proc Natl Acad Sci U S A 115:3126-3131
Krauthammer, Michael (2018) Unraveling the etiology of primary malignant melanoma of the esophagus. J Thorac Dis 10:S1074-S1075
Das, Rituparna; Bar, Noffar; Ferreira, Michelle et al. (2018) Early B cell changes predict autoimmunity following combination immune checkpoint blockade. J Clin Invest 128:715-720
Miller, Chad J; Muftuoglu, Yagmur; Turk, Benjamin E (2017) A high throughput assay to identify substrate-selective inhibitors of the ERK protein kinases. Biochem Pharmacol 142:39-45
Kluger, Harriet M; Zito, Christopher R; Turcu, Gabriela et al. (2017) PD-L1 Studies Across Tumor Types, Its Differential Expression and Predictive Value in Patients Treated with Immune Checkpoint Inhibitors. Clin Cancer Res 23:4270-4279

Showing the most recent 10 out of 172 publications